Compare Hinge Health Inc. Class A Common Stock (HNGE) vs Zillow Group Inc Class A (ZG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hinge Health Inc. Class A Common Stock vs Zillow Group Inc Class A — how do they compare? Hinge Health Inc. Class A Common Stock trades at $104.95 (market cap $8.48B), while Zillow Group Inc Class A trades at $29.53 (market cap $6.33B). The key difference: Hinge Health Inc. Class A Common Stock is the larger of the two by market cap, and Hinge Health Inc. Class A Common Stock is trading nearer its 52-week high, Zillow Group Inc Class A nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Hinge Health Inc. Class A Common Stock for 0 Days and Zillow Group Inc Class A for 86 Days on average.
| HNGE | ZG | |
|---|---|---|
Market Cap | $8.48B | $6.33B |
Volume | 879,799 | 1,202,678 |
Sector | Health | Media |
52-Week High | $105.14 | $74.58 |
52-Week Low | $31.17 | $27.70 |
Typical Hold Time | 0 Days | 86 Days |
Enterprise Value | $8.10B | $6.21B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Hinge Health (HNGE) trades at $105.14, up 0.31% on the day and near its 52-week high. The stock shows strong analyst support with a 93.75% buy rating, though the current price exceeds the consensus target of $101.62. Recent earnings beat expectations in two of the last three quarters, with Q3 2026 results due November 2. Fundamentals indicate robust revenue growth projections from $588 million in 2025 to $720 million in 2026, alongside a shift to profitability, but valuation multiples like EV/EBITDA at 82.33 remain elevated.
The outlook is cautiously optimistic given projected profitability and expansion into migraine and GI care, but risks include high insider selling, competitive pressures, and the stock's premium valuation. Execution on growth targets and Q3 earnings will be critical for sustaining momentum.
Zillow Group (ZG) trades at $29.27, up 2.02% today, amid a challenging housing market. The stock is technically bearish, trading near its pivot point of $29, with key resistance at $30 and support at $28. Fundamentally, the company has returned to profitability in 2025 with a net income of $23 million, a significant improvement from prior years' losses, though its P/E ratio of 125.43 remains high. Recent news highlights competitive pressures and interest rate sensitivity.
The outlook is mixed. Analyst consensus is a 'Hold' with a $48.60 price target, implying substantial upside, but execution on its integrated transaction platform and navigating housing affordability headwinds are key. Risks include market volatility and a high valuation. The path to sustained profitability will be the primary driver for the stock.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Hinge Health Inc. Class A Common Stock
Hinge Health Inc. operates a digital musculoskeletal (MSK) care platform that delivers exercise therapy for joint and muscle conditions through health plans and employers. Its Precision Motion Technology combines wearable sensors and computer vision to guide patients through clinician-directed physical therapy remotely.
Read more on HNGE →About Zillow Group Inc Class A
Zillow Group is an Internet-based real estate company that has historically focused on deriving ad revenue from third-party brokers on online marketplaces such as Zillow.com, Trulia, and HotPads. More recently it has shifted its focus to iBuying via the Zillow Offers platform.
Read more on ZG →
